Login to Your Account

With a majority stake in Ruide, Australia’s CSL becomes the Chinese market leader

By David Ho
Staff Writer

Wednesday, June 14, 2017

HONG KONG – CSL Ltd. has bought a majority stake in China’s Wuhan Zhong Yuan Ruide Biological Products Co. Ltd. in a $352 million deal that should make the Australian biotech company a market leader.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription